Price variability of TNF-α inhibitor biosimilars among European countries.

Subjects

Subjects :

Europe
Humans
Tumor Necrosis Factor-alpha antagonists & inhibitors
Infliximab economics
Infliximab therapeutic use
Drug Costs
Adalimumab therapeutic use
Adalimumab economics
Biosimilar Pharmaceuticals economics
Biosimilar Pharmaceuticals therapeutic use

Details

Language :

English

ISSN :

1468-3083

Volume :

38

Issue :

8

Database :

MEDLINE

Journal :

Journal of the European Academy of Dermatology and Venereology : JEADV

Publication Type :

Editorial & Opinion

Accession number :

38108512

Full Text :

https://doi.org/10.1111/jdv.19756